Abstract
To develop anti-tetanus human monoclonal antibodies (MAbs) applicable for clinical use, five hybrid cell lines (human lymphocytes-a mouse/human heteromyeloma SHM-D33 or RF-S1) stably producing human MAbs with high toxin-neutralizing activity in large amounts in serum-free medium were established. The MAbs they produced were the IgG type, had very high affinity (Ka ca. 1011 M-1) and were directed against one of the three domains [A], [B] or [C] of the tetanus toxin molecule. Their protective effects were studied in comparison with that of polyclonal antibody by observing the effects on progress of tetanus symptoms of mice. Mice injected im with toxin pretreated in vitro with the individual MAbs above sufficient doses survived, although at doses below the sufficient doses, delayed intoxication and progress of symptoms over 96 h and delayed death of the mice were observed. Injection iv of the individual MAbs or their mixtures at over doses equivalent to 0.03~0.1 IU per mouse protected from subsequent challenge with 20 MLD of toxin. Mice injected im with 4 MLD of toxin could be protected by iv injection of individual MAbs or mixture at doses equivalent to 0.03 IU per mouse, even 10 h after injection of toxin. Thus these human MAbs should be useful for prevention and treatment of human tetanus.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kamei, M., Hashizume, S., Sugimoto, N., Ozutsumi, K. and Matsuda, M.(1990) ‘Establishment of stable mouse/human-human hybrid cell lines producing large amounts of anti-tetanus human monoclonal antibodies with high neutralizing activity’, Eur. J. Epidemiol. 6, 386–397.
Kimoto, H. (1985) ‘A method for estimating the affinity of monoclonal antibodies a solid phase method’, Saibo-kogaku (Cell Technology) 4, 792–796 (in Japanese).
Matsuda, M., Sugimoto, N. and Ozutsumi, K. (1982) ‘Acute botulinum-like intoxication by tetanus toxin in mice and the localization of the acute toxicity in the N-terminal papain-fragment of the toxin’, in Proceedings of the 6th International Conference on Tetanus, Fondation Marcel Merieux, Lyon, pp. 21–32.
Matsuda, M. and Yoneda, M. (1975) ‘Isolation and purification of two antigenically active, “complementary” polypeptide fragments of tetanus neurotoxin,’ Infect. Immun. 12, 1147–1153.
Ozutsumi, K., Lei, D-L., Sugimoto, N. and Matsuda, M. (1989) ‘Isolation and purification by high performance liquid chromatography of a tetanus toxin fragment (Fragment [A-B]) derived from mildly papain-treated toxin,’ Toxicon 27, 1055–1057.
van Heyningen, W.E. and Mellanby, J.H. (1971) ‘Tetanus toxin.’ in Microbial Toxins. Vol. 3, S. Kadis, T.C. Montie and S.J. Ajl (eds.), Academic Press, New York, pp. 69–108.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Matsuda, M., Kamei, M., Sugimoto, N., Hashizume, S. (1993). Application of Anti-Tetanus Human Monoclonal Antibodies. In: Kaminogawa, S., Ametani, A., Hachimura, S. (eds) Animal Cell Technology: Basic & Applied Aspects. Animal Cell Technology: Basic & Applied Aspects, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2044-9_84
Download citation
DOI: https://doi.org/10.1007/978-94-011-2044-9_84
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4905-4
Online ISBN: 978-94-011-2044-9
eBook Packages: Springer Book Archive